Article: Tumour mutational burden: a review

Related products

• 

  1 year access Online Belgian Journal of Hematology (BJH)

  €43.60 Add to cart
• 

  Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

  €2.42 Add to cart
• 

  Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

  €2.42 Add to cart
• 

  Article: Highlights in urologic cancer

  €2.42 Add to cart